BlackRock’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.47M Buy
12,316,955
+971,836
+9% +$1.01M ﹤0.01% 3664
2025
Q4
$10.9M Buy
11,345,119
+1,443,324
+15% +$2.04M ﹤0.01% 3418
2025
Q3
$17.2M Sell
9,901,795
-43,653
-0.4% -$85.5K ﹤0.01% 3169
2025
Q2
$20.8M Buy
9,945,448
+1,720,304
+21% +$3.3M ﹤0.01% 2998
2025
Q1
$14M Buy
8,225,144
+177,559
+2% +$667K ﹤0.01% 3138
2024
Q4
$40.6M Buy
8,047,585
+508,246
+7% +$2.51M ﹤0.01% 2587
2024
Q3
$41M Buy
7,539,339
+399,325
+6% +$2.63M ﹤0.01% 2596
2024
Q2
$34.3M Buy
7,140,014
+2,351,274
+49% +$12.2M ﹤0.01% 2653
2024
Q1
$14.9M Sell
4,788,740
-110,549
-2% -$372K ﹤0.01% 3147
2023
Q4
$13.9M Buy
4,899,289
+398,803
+9% +$1.02M ﹤0.01% 3217
2023
Q3
$13.2M Buy
4,500,486
+195,981
+5% +$648K ﹤0.01% 3165
2023
Q2
$12.3M Buy
4,304,505
+501,265
+13% +$1.81M ﹤0.01% 3315
2023
Q1
$11.8M Sell
3,803,240
-207,162
-5% -$589K ﹤0.01% 3233
2022
Q4
$8.46M Buy
4,010,402
+1,799,047
+81% +$5.46M ﹤0.01% 3471
2022
Q3
$7.21M Sell
2,211,355
-185,023
-8% -$710K ﹤0.01% 3593
2022
Q2
$7.69M Buy
2,396,378
+818,459
+52% +$4.55M ﹤0.01% 3630
2022
Q1
$11.1M Buy
1,577,919
+176,846
+13% +$1.03M ﹤0.01% 3519
2021
Q4
$10.2M Buy
+1,401,073
New +$13.9M ﹤0.01% 3665

Other funds holding HUMA